Arlington Trust’s Bio-Techne TECH Stock Holding History

Arlington Trust’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-30	Closed	-$2.4K	–	576
2024 Q3	$2.4K	Buy	+30	New	+$2.25K	﹤0.01%	521
2024 Q1	–	Sell	-22	Closed	-$1.7K	–	847
2023 Q4	$1.7K	Buy	+22	New	+$1.45K	﹤0.01%	668

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Arlington Trust's TECH Position: Q4 2024 in Review

Arlington Trust sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 30 shares — an estimated $2.4K sold.

Arlington Trust first reported a position in TECH in Q4 2023 and held it in 2 quarters. The position peaked at $2.4K in Q3 2024. 577 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

Arlington Trust reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
Arlington Trust sold 30 Bio-Techne shares in Q4 2024, an estimated $2.4K.
Arlington Trust first reported a position in Bio-Techne in Q4 2023 and held it in 2 quarters.
Arlington Trust's Bio-Techne position peaked at $2.4K in Q3 2024.
577 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on Arlington Trust's 13F filing for Q4 2024, filed 29 Jan 2025.